Nicergoline: Clinical Trials

5 trials of Nicergoline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 terminated. 2 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1
Phase 32Completed 1, Terminated 1

Follow Nicergoline: new trials by email Literature Review of Nicergoline trials Research Report on Nicergoline

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploring the Cognitive Benefits of a Blackcurrant-Based Supplement in Normobaric Hypoxia
Nootropics (ginkgo biloba, nicergoline, piracetam, or others), Placebo - Cognitive Performance, Executive Function (Cognition)
Not applicableNot yet recruitingLeeds Beckett University272025-09-012025-09-10
Effect of a Plant Based Nootropic on Perceptual Decision Making.
Nootropics (ginkgo biloba, nicergoline, piracetam, or others), Placebo, Perceptual decision-making performance - Cognitive Enhancement
Not applicableCompletedUniversity of Leeds372023-10-232024-11-14
Nicergoline Use in Dysphagia Patients
Nicergoline - Dysphagia
Phase 3CompletedPhramongkutklao College of Medicine and Hospital922023-01-012026-03-04
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine
Galantamine, Nootropics (ginkgo biloba, nicergoline, piracetam, or others) - Dementia, Alzheimer Disease
CompletedJanssen-Cilag G.m.b.H11342006-03-012014-06-18

Conditions studied

Dementia (3)  ·  Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Behavioral Symptoms (1)  ·  Deglutition Disorders (1)  ·  Dementia, Vascular (1)  ·  Depression (1)  ·  Neurobehavioral Manifestations (1)  ·  Parkinson Disease (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)  ·  Stroke (1)

Sponsors

Hannover Medical School (1)  ·  Janssen-Cilag G.m.b.H (1)  ·  Leeds Beckett University (1)  ·  Phramongkutklao College of Medicine and Hospital (1)  ·  University of Leeds (1)

Countries

United Kingdom (2)  ·  Germany (1)  ·  Thailand (1)

Top investigators

Helge Frieling, Prof., MD (1)  ·  Ioannis Delis (1)  ·  Juthathip Suphanklang, BCP (1)  ·  Jutikan Imsub, PharmD (1)  ·  Pasiri Sithinamsuwan, MD (1)  ·  Sittichoke Sirimontakan, MD (1)

Results publications

PMID 40149748